BDNF and myeloid sarcoma: Notably, our findings demonstrate a significant reduction in the expression of neurotrophic factors within the MS group, specifically persephin, neurotrophin-3 (NT-3), and brain-derived neurotrophic factor (BDNF) (Figures 2C–E).